Antiretroviral therapy targeting HIV-1 viral infectivity factor; in silico approach

被引：0
|
作者：
Karau, Muriira G. [1 ]
Karau, Bundi P. [2 ]
机构：
[1] Egerton Univ, Nairobi, Kenya
[2] Univ Nairobi, Fac Hlth Sci, Nairobi, Kenya
来源：
RETROVIROLOGY | 2009年 / 6卷
关键词：
Cell Epitope; Dimerization Domain; Swissprot Database; Surface Accessibility; Accessibility Prediction;
D O I：
10.1186/1742-4690-6-S2-P45
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Designed antiviral ankyrin - A computational approach to combat HIV-1 via intracellular pathway by targeting the viral capsid of HIV-1
    Karim, Hana Atiqah Abdul
    Rungrotmongkol, Thanyada
    Zain, Sharifuddin M.
    Abd Rahman, Noorsaadah
    Tayapiwattana, Chatchai
    Lee, VannajanSanghiran
    JOURNAL OF MOLECULAR LIQUIDS, 2019, 277 : 63 - 69
  • [42] HIV-1 Subtypes and Primary Antiretroviral Resistance Mutations in Antiretroviral Therapy Naive HIV-1 Infected Individuals in Turkey
    Sayan, M.
    Willke, A.
    Ozgunes, N.
    Sargin, F.
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2013, 66 (04) : 306 - 311
  • [43] In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy
    Tanya Lynn Applegate
    Donald John Birkett
    Glen John Mcintyre
    Angel Belisario Jaramillo
    Geoff Symonds
    John Michael Murray
    Retrovirology, 7
  • [44] Immunological recovery and antiretroviral therapy in HIV-1 infection
    Battegay, M
    Nuesch, R
    Hirschel, B
    Kaufmann, GR
    LANCET INFECTIOUS DISEASES, 2006, 6 (05): : 280 - 287
  • [45] Can HIV-1 superinfection compromise antiretroviral therapy?
    Chakraborty, B
    Kiser, P
    Rangel, HR
    Weber, A
    Mirza, M
    Marotta, ML
    Asaad, R
    Rodriguez, B
    Valdez, H
    Lederman, MM
    Quiñones-Mateu, ME
    AIDS, 2004, 18 (01) : 132 - 134
  • [46] Delayed HIV-1 seroconversion after antiretroviral therapy
    Apetrei, C
    Tamalet, C
    Edlinger, C
    Damond, F
    Descamps, D
    Saimot, AG
    Brun-Vézinet, F
    Simon, F
    AIDS, 1998, 12 (14) : 1935 - 1936
  • [47] In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy
    Applegate, Tanya Lynn
    Birkett, Donald John
    Mcintyre, Glen John
    Jaramillo, Angel Belisario
    Symonds, Geoff
    Murray, John Michael
    RETROVIROLOGY, 2010, 7
  • [48] A quantitative basis for antiretroviral therapy for HIV-1 infection
    Jilek, Benjamin L.
    Zarr, Melissa
    Sampah, Maame E.
    Rabi, S. Alireza
    Bullen, Cynthia K.
    Lai, Jun
    Shen, Lin
    Siliciano, Robert F.
    NATURE MEDICINE, 2012, 18 (03) : 446 - U211
  • [49] A quantitative basis for antiretroviral therapy for HIV-1 infection
    Benjamin L Jilek
    Melissa Zarr
    Maame E Sampah
    S Alireza Rabi
    Cynthia K Bullen
    Jun Lai
    Lin Shen
    Robert F Siliciano
    Nature Medicine, 2012, 18 : 446 - 451
  • [50] Prevention of HIV-1 Infection with Early Antiretroviral Therapy
    Cohen, Myron S.
    Chen, Ying Q.
    McCauley, Marybeth
    Gamble, Theresa
    Hosseinipour, Mina C.
    Kumarasamy, Nagalingeswaran
    Hakim, James G.
    Kumwenda, Johnstone
    Grinsztejn, Beatriz
    Pilotto, Jose H. S.
    Godbole, Sheela V.
    Mehendale, Sanjay
    Chariyalertsak, Suwat
    Santos, Breno R.
    Mayer, Kenneth H.
    Hoffman, Irving F.
    Eshleman, Susan H.
    Piwowar-Manning, Estelle
    Wang, Lei
    Makhema, Joseph
    Mills, Lisa A.
    de Bruyn, Guy
    Sanne, Ian
    Eron, Joseph
    Gallant, Joel
    Havlir, Diane
    Swindells, Susan
    Ribaudo, Heather
    Elharrar, Vanessa
    Burns, David
    Taha, Taha E.
    Nielsen-Saines, Karin
    Celentano, David
    Essex, Max
    Fleming, Thomas R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (06): : 493 - 505
12345